Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
All content curated by
featured
Published in Diabetes

Journal Scan / Research · August 15, 2024

Comparison of Renal Prognosis Between DPP-4 Inhibitor Users and Non-Users

Diabetes, Obesity & Metabolism

 

Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes, Obesity & Metabolism
Comparison of renal prognosis between dipeptidyl peptidase-4 inhibitor users and non-users
Diabetes Obes Metab 2024 Jul 31;[EPub Ahead of Print], H Hashimoto, M Satoh, S Nakayama, M Toyama, T Murakami, T Obara, N Nakaya, T Mori, A Hozawa, H Metoki

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading